Pharma Integration
Pharma Integration is an Italian engineering firm that designs and sells the Azzurra platform, a family of fully robotic, gloveless, humanless aseptic fill-finishing systems for pharmaceutical and biotech manufacturers of injectables, advanced biologics, and cell and gene therapies.
- Company typePrivate
- Founded2016
- HeadquartersSiena, Italy
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pharma Integration does
Pharma Integration SRL is an Italian privately held engineering company founded in 2016 and headquartered in Siena, within an Italian Pharma Park focused on life sciences. The company designs and manufactures the Azzurra platform — a family of fully robotic, gloveless, and humanless aseptic fill-finish systems (Azzurra Micro for micro-batch production, Azzurra Small for small-batch vials/syringes/cartridges, and Azzurra FAB for campaign-long production in a room isolator). The platform is built on 6-axis Denso robotic arms performing denesting, filling, stoppering, capping and renesting within a monobloc architecture that integrates the isolator, VHP generator, HVAC, and unified control systems into a single factory-assembled, pre-qualified unit, complemented by a proprietary No-Touch-Transfer tub debagging system with a Grade B intermediate zone and UV-C Tyvek decontamination.
Pharma Integration generates revenue primarily through direct enterprise sales of high-value Azzurra capital equipment to pharmaceutical drug-product manufacturers, biotech multiproduct facilities, and emerging cell-and-gene-therapy producers, supplemented by installation/qualification services and recurring consumables from the co-developed BioCapt Single-Use Microbial Impactor AutoM. The go-to-market is consultative field sales supported by ISPE conference participation, technical webinars, and whitepapers. Regulatory positioning is a core pillar: the Azzurra platform is reportedly the first fill-finish system of its kind admitted to both the FDA Emerging Technology Program and the EMA Quality Innovation Group, and the company holds ISO 9001:2015 (Bureau Veritas) and ACCREDIA certifications.
The company is privately held, with ownership concentrated among co-founders Claudio Bechini (Managing Director) and Cinzia Butini (VP of Engineering), together with strategic minority investors PM Group and Euromatic, which provided an undisclosed capital injection in August 2025 to fund Azzurra platform development and international expansion. Operations remain based in Siena, Italy, with stated commercial reach into the United States and broader European Union.
Pharma Integration firmographics
Firmographics- Name
- Pharma Integration
- Legal name
- Pharma Integration SRL
- Website
- https://pharma-integration.it
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Pharma Integration is an Italian engineering firm that designs and sells the Azzurra platform, a family of fully robotic, gloveless, humanless aseptic fill-finishing systems for pharmaceutical and biotech manufacturers of injectables, advanced biologics, and cell and gene therapies.
- Ownership category
- akta.pro rank
Pharma Integration industry classification
Industry- Product category
- Pharmaceutical Manufacturing Equipment
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Process Analytical Technology (PAT) & In-Line/At-Line Analytics (spectroscopy, sensors, monitoring) (HLAAAJAD)
- akta.pro secondary industry
- Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors) (HLAAAJAC)
Keywords
Where Pharma Integration is headquartered
LocationHeadquarters
- HQ city
- Siena
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
Pharma Integration business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Robotic Fill-Finish Systems Sales: Sale of Azzurra platform systems including Azzurra Micro, Azzurra Small, and Azzurra FAB. These are modular, fully robotic, gloveless and humanless fill-finish systems for aseptic processing. Revenue is generated through one-time capital equipment sales with likely professional services for installation and qualification.
- Environmental Monitoring Solutions: Sale of BioCapt Single-Use Microbial Impactor AutoM for robotic pharmaceutical manufacturing environments. Single-use plates for active microbial air sampling.
- Professional Services: Installation, qualification, and support services associated with monobloc system deployment. Factory-tested systems reduce on-site CQV burden.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Pharma Integration product offering
Product offeringCore offering
Pharma Integration designs, manufactures, and sells the Azzurra family of fully modular, gloveless, and humanless robotic fill-finish systems for aseptic processing of small-volume parenterals (vials, syringes, cartridges). The monobloc architecture integrates 6-axis robotic arms, isolator, VHP generator, and on-board HVAC into a single factory-tested unit delivered plug-and-play. The company also offers the co-developed BioCapt Single-Use Microbial Impactor AutoM for robotic environmental monitoring.
Product overview
Pharma Integration provides cutting-edge robotic fill-finishing systems for small-volume parenterals and next-generation drugs. The Azzurra platform is a family of three fully modular, gloveless, and humanless robotic fill-finish systems: Azzurra Micro (two-module R&D solution for micro-batch production), Azzurra Small (four-module solution for small-batch production), and Azzurra FAB (miniature room isolator for campaign-long production). All Azzurra systems feature monobloc design integrating robotic process unit, isolator, VHP generator, on-board HVAC, and unified control systems. Complementing the fill-finish portfolio is the BioCapt Single-Use Microbial Impactor AutoM, a co-developed environmental monitoring solution designed for robotic accessibility. The complete portfolio operates on a philosophy of standardization, flexibility, and regulatory alignment with Quality by Design principles.
Differentiator
Problem solved
Functional benefit
Brands
- Azzurra: Family of fully modular, gloveless and humanless, robotic fill-finish systems designed for aseptic processing of small volume parenterals. Includes Azzurra Micro (R&D module for micro-batch), Azzurra Small (four-module solution for small-batch), and Azzurra FAB (miniature room isolator for campaign-long production).
- BioCapt Single-Use Microbial Impactor AutoM
- BCSU AutoM
Products and services
- Azzurra Micro A two-robotic-module monobloc aseptic fill-finishing solution designed for micro-batch production, ideal for cell and gene therapies, clinical trials, and personalized medicine manufacturing.
- Azzurra Small The first fully robotic monobloc system with four compact robotic modules for small-batch aseptic production, handling vials, syringes and cartridges (RTU and bulk) with any closure type. Achieves downtime between batches under 4 hours and decontamination cycles under 60 minutes.
- Azzurra FAB An automated, humanless, and gloveless robotic fill-finish system within an isolated room enclosure, designed for campaign-long production of small-volume parenterals.
- BioCapt Single-Use Microbial Impactor AutoM Single-use plate for active viable air sampling within robotic pharmaceutical manufacturing environments, co-developed with Particle Measuring Systems. Features a magnetic lid design for robotic handling, liquid-tight seal to prevent vapor penetration (VHP), supports up to 4 hours of continuous monitoring, and is compliant with EU GMP Annex 1 and ISO 14698-1.
Quantifiable outcome
- Downtime between batches: Less than 4 hours
- +4 more outcomes
Companies that use Pharma Integration
Customer profileSegments3 records
Ideal customer profiles2 records
Pharma Integration technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature7 records
Pharma Integration partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered key and core.
- ServiTecnokeyStrategic partnership integrating GE Vernova iFIX HMI/SCADA system into Azzurra platforms for real-time data control, intuitive interfaces, and robust cybersecurity. ServiTecno collaboration enables advanced software integration with robotics.
- SiemenskeyStrategic partnership leveraging Siemens industrial PCs and advanced automation controls. Integration of operational technology (OT) with informative technology (IT) achieving high-performance industrial automation within Industry 4.0 and 5.0 environments.
- Particle Measuring SystemscoreCo-developed the BioCapt Single-Use Microbial Impactor AutoM, a patented robotic-accessible microbial air sampling solution. Two innovative patents resulted from this collaboration. The product is specifically designed for robotic manipulation in pharmaceutical manufacturing environments.
- FaulhabercoreProvider of advanced drive systems for Azzurra robotic automation. Faulhaber motors are renowned for compact size, precision, and exceptional performance, providing the reliability and accuracy needed for pharmaceutical manufacturing.
- DensocoreProvider of 6-axis robotic arms used in Azzurra Small system. Denso robots perform critical fill-finishing operations including denesting, filling, stoppering, capping, and renesting within the monobloc system.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Pharma Integration competitors and assessment
Company assessmentBroad incumbents
- Cytiva (formerly GE Healthcare Life Sciences): Global supplier of bioprocessing and fill-finish equipment for biologics, vaccines and advanced therapies. Competes with Pharma Integration especially in cell/gene therapy and multiproduct flexible manufacturing segments.
- IMA S.p.A. Italian-headquartered global leader in pharmaceutical processing and packaging machinery, including aseptic fill-finish lines. Competes with Pharma Integration across sterile injectable fill-finish but operates a far broader equipment and services portfolio.
- Stevanato Group: Italian-headquartered supplier of glass primary packaging and integrated fill-finish systems for injectable drugs. Both a potential partner and a competitor to Pharma Integration in aseptic processing and turnkey solutions.
- Syntegon Technology (formerly Bosch Packaging Technology): Major global supplier of processing and packaging equipment for pharmaceuticals, including robotic and isolator-based aseptic fill-finish systems. Overlaps directly with Azzurra's customer base and use cases.
- GEA Group (Pharma Spray Dryers & Containment): Large industrial conglomerate with a pharmaceutical processing and fill-finish equipment portfolio serving injectable drug manufacturers. Broader scope than Pharma Integration but competes in the same aseptic processing customer set.
- Becton, Dickinson and Company (BD) — Pharmaceutical Systems: Global medical device leader whose Pharmaceutical Systems division supplies pre-fillable syringes, vials and combination products, with growing interest in fill-finish equipment and services. Competes in sterile injectable packaging workflows that overlap with Azzurra's RTU syringe and vial use cases.
Direct peers
- Groninger & Co. GmbH: German specialist in filling and closing machinery for pharmaceuticals and cosmetics, with deep expertise in aseptic fill-finish for vials, syringes and cartridges — directly comparable to Azzurra Small in target containers and customer segments.
- Optima Pharma GmbH: German specialist in aseptic filling and isolator technology for vials, syringes and cartridges. Directly competes with Pharma Integration for aseptic fill-finish contracts with injectables manufacturers.
Emerging players
- Watson-Marlow (Spirax-Sarco): Provider of peristaltic pumps and fluid path components for biopharmaceutical fill-finish applications. Adjacent to Pharma Integration, supplying components into fill-finish lines similar to Azzurra's customers.
Regional players
- Astell Scientific: UK-based manufacturer of sterilization, washing and isolation equipment for pharmaceutical production. Overlaps in aseptic and contamination-control technology adjacent to Pharma Integration's monobloc/isolator approach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Pharma Integration social profiles
Digital presencePharma Integration compliance and trust
Trust signalCompliance5 records
Pharma Integration financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharma Integration leadership team
Management profileNumber of profiles
Profiles3 records
Pharma Integration funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharma Integration M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharma Integration
What does Pharma Integration do?
Pharma Integration designs, manufactures, and sells the Azzurra family of fully modular, gloveless, and humanless robotic fill-finish systems for aseptic processing of small-volume parenterals (vials, syringes, cartridges). The monobloc architecture integrates 6-axis robotic arms, isolator, VHP generator, and on-board HVAC into a single factory-tested unit delivered plug-and-play. The company also offers the co-developed BioCapt Single-Use Microbial Impactor AutoM for robotic environmental monitoring.
Is Pharma Integration a public or private company?
Pharma Integration is a private company. It is classified as venture growth investor backed and is currently operating.
When was Pharma Integration founded?
Pharma Integration was founded in 2016. It employs 11 to 50 people.
Where is Pharma Integration based?
Pharma Integration is headquartered in Siena, Italy, in the Europe region.
How does Pharma Integration make money?
Three revenue lines are on record. Robotic Fill-Finish Systems Sales are the primary driver. The others are environmental Monitoring Solutions and professional Services.
Who are Pharma Integration's main competitors?
Broad incumbents on record are Cytiva (formerly GE Healthcare Life Sciences), IMA S.p.A., Stevanato Group, Syntegon Technology (formerly Bosch Packaging Technology), GEA Group (Pharma Spray Dryers & Containment) and Becton, Dickinson and Company (BD) — Pharmaceutical Systems. Direct peers are Groninger & Co. GmbH and Optima Pharma GmbH. Watson-Marlow (Spirax-Sarco) is listed as an emerging player. Astell Scientific is listed as a regional player.
Does Pharma Integration have an API?
No public API is recorded for Pharma Integration.
What industry is Pharma Integration in?
Pharma Integration's product category is Pharmaceutical Manufacturing Equipment. Its primary akta.pro industry code is HLAAAJAD, Process Analytical Technology (PAT) & In-Line/At-Line Analytics (spectroscopy, sensors, monitoring), with a secondary code of HLAAAJAC, Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors). Its NAICS code is 3345 and its SIC code is 3841.